CoChat

Oleate prevents palmitate-induced atrophy via modulation of mitochondrial ROS production in skeletal myotubes.

Open access
Lee, Hojun, Lim, Jae-Young, Choi, Seung-Jun · 2017 · Oxidative Medicine and Cellular Longevity

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Abstract

Accumulation of saturated fatty acids contributes to lipotoxicity‐related insulin resistance and atrophy in skeletal muscle. Conversely, unsaturated fatty acids like docosahexaenoic acid were proven to preserve muscle mass. However, it is not known if the most common unsaturated oleate will protect skeletal myotubes against palmitate‐mediated atrophy, and its specific mechanism remains to be elucidated. Therefore, we investigated the effects of oleate on atrophy‐related factors in palmitate‐conditioned myotubes. Exposure of myotubes to palmitate, but not to oleate, led to an induction of fragmented nuclei, myotube loss, atrophy, and mitochondrial superoxide in a dose‐dependent manner. Treatment of oleate to myotubes attenuated production of palmitate‐induced mitochondrial superoxide in a dose‐dependent manner. The treatment of oleate or MitoTEMPO to palmitate‐conditioned myotubes led to inhibition of palmitate‐induced mRNA expression of proinflammatory (TNF‐α and IL6), mitochondrial fission (Drp1 and Fis1), and atrophy markers (myostatin and atrogin1). In accordance with the gene expression data, our immunocytochemistry experiment demonstrated that oleate and MitoTEMPO prevented or attenuated palmitate‐mediated myotube shrinkage. These results provide a mechanism indicating that oleate prevents palmitate‐mediated atrophy via at least partial modulation of mitochondrial superoxide production.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2017/2739721

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The effects of palmitic and oleic acid on morphological features of myotubes. Differentiated C2C12 myotubes were treated with 0.1, 0.3, 0.5, and 1 mM palmitate or oleate for 36 h. (a) Differentiated myotubes were stained with MF20 antibody and were visualized by florescence microscope (magnification = ×20). (b) Myotube number, (c) width, and (d) length were quantified. Bar graph represented means ± SE. Scale bar = 100 μm. The data were analyzed using two-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT. NT: nontreatment.
Figure 1 The effects of palmitic and oleic acid on morphological features of myotubes. Differentiated C2C12 myotubes were treated with 0.1, 0.3, 0.5, and 1 mM palmitate or oleate for 36 h. (a) Differentiated myotubes were stained with MF20 antibody and were visualized by florescence microscope (magnification = ×20). (b) Myotube number, (c) width, and (d) length were quantified. Bar graph represented means ± SE. Scale bar = 100 μm. The data were analyzed using two-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT. NT: nontreatment.CC BY · PubMed Central
Figure 2 The effects of palmitic and oleic acid on morphological features of myonuclei. Differentiated C2C12 myotubes were treated with 0.1, 0.3, 0.5, and 1 mM palmitate or oleate for 36 h. (a) Myonuclei were stained with DAPI and were visualized by florescence microscope (magnification = ×64). (b) Total myonucleus number, (b) fragmented myonuclei, and (c) fragmented myonuclei (%) were quantified. Bar graph represented means ± SE. Scale bar = 20 μm. The data were analyzed using two-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT. NT: nontreatment.
Figure 2 The effects of palmitic and oleic acid on morphological features of myonuclei. Differentiated C2C12 myotubes were treated with 0.1, 0.3, 0.5, and 1 mM palmitate or oleate for 36 h. (a) Myonuclei were stained with DAPI and were visualized by florescence microscope (magnification = ×64). (b) Total myonucleus number, (b) fragmented myonuclei, and (c) fragmented myonuclei (%) were quantified. Bar graph represented means ± SE. Scale bar = 20 μm. The data were analyzed using two-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT. NT: nontreatment.CC BY · PubMed Central
Figure 3 The effects of palmitic and oleic acid on mitochondrial superoxide production. (a) Differentiated C2C12 myotubes were treated with 0.3 mM palmitate or 0.3 mM oleate at the indicated time points. Differentiated myotubes were stained with MitoSOX. (b) Differentiated myotubes were cotreated with 0.3 mM palmitate and different doses of oleate (0.1, 0.3, 0.5, and 1 mM) for 30 h and were visualized by florescence microscope (magnification = ×20). (c) Dose effects of palmitic and oleic acid and (d) protective effects of oleic acid in palmitic acid-treated myotubes were quantified. Bar graph represented means ± SE. Scale bar = 100 μm. The data were analyzed using one or two-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT. NT: non-treatment.
Figure 3 The effects of palmitic and oleic acid on mitochondrial superoxide production. (a) Differentiated C2C12 myotubes were treated with 0.3 mM palmitate or 0.3 mM oleate at the indicated time points. Differentiated myotubes were stained with MitoSOX. (b) Differentiated myotubes were cotreated with 0.3 mM palmitate and different doses of oleate (0.1, 0.3, 0.5, and 1 mM) for 30 h and were visualized by florescence microscope (magnification = ×20). (c) Dose effects of palmitic and oleic acid and (d) protective effects of oleic acid in palmitic acid-treated myotubes were quantified. Bar graph represented means ± SE. Scale bar = 100 μm. The data were analyzed using one or two-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT. NT: non-treatment.CC BY · PubMed Central
Figure 4 The effects of oleic acid and MitoTEMPO on mitochondrial biogenesis and dynamics in PA-treated myotubes. (a) Differentiated myotubes were cotreated with 0.3 mM palmitate and different doses of oleate (0.1, 0.3, 0.5, and 1 mM) for 30 h. The myotubes were visualized by florescence microscope after MitoTracker staining. (b) Florescence intensity of MitoTracker was quantified. (c) Gene expressions of mitochondrial fission, (d) fusion, and (e) biogenesis were quantified. Differentiated myotubes were cotreated with 0.3 mM palmitate and/or 0.5 mM oleate for 30 h. For some cells, 25 nM of MitoTEMPO was treated 1 h prior to palmitate treatment. Bar graph represented means ± SE. Scale bar = 100 μm. The data were analyzed using one-way ANOVA followed by a Tukey's post hoc test. ∗p < 0.05 versus NT. NT: nontreatment; PA: palmitic acid; PA + OA: palmitic acid with oleic acid; PA + MitoT: palmitic acid + MitoTEMPO.
Figure 4 The effects of oleic acid and MitoTEMPO on mitochondrial biogenesis and dynamics in PA-treated myotubes. (a) Differentiated myotubes were cotreated with 0.3 mM palmitate and different doses of oleate (0.1, 0.3, 0.5, and 1 mM) for 30 h. The myotubes were visualized by florescence microscope after MitoTracker staining. (b) Florescence intensity of MitoTracker was quantified. (c) Gene expressions of mitochondrial fission, (d) fusion, and (e) biogenesis were quantified. Differentiated myotubes were cotreated with 0.3 mM palmitate and/or 0.5 mM oleate for 30 h. For some cells, 25 nM of MitoTEMPO was treated 1 h prior to palmitate treatment. Bar graph represented means ± SE. Scale bar = 100 μm. The data were analyzed using one-way ANOVA followed by a Tukey's post hoc test. ∗p < 0.05 versus NT. NT: nontreatment; PA: palmitic acid; PA + OA: palmitic acid with oleic acid; PA + MitoT: palmitic acid + MitoTEMPO.CC BY · PubMed Central
Figure 5 The effects of oleic acid and MitoTEMPO on the expression of proinflammatory cytokines in PA-treated myotubes. Differentiated myotubes were cotreated with 0.3 mM palmitate and/or 0.5 mM oleate for 30 h. For some cells, 25 nM of MitoTEMPO was treated 1 h prior to palmitate treatment. The gene expressions of TNF-α, IL6, and IL1-β were quantified. Bar graph represented means ± SE. The data were analyzed using one-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT. NT: nontreatment; PA: palmitic acid; PA + OA: palmitic acid with oleic acid; PA + MitoT: palmitic acid with MitoTEMPO.
Figure 5 The effects of oleic acid and MitoTEMPO on the expression of proinflammatory cytokines in PA-treated myotubes. Differentiated myotubes were cotreated with 0.3 mM palmitate and/or 0.5 mM oleate for 30 h. For some cells, 25 nM of MitoTEMPO was treated 1 h prior to palmitate treatment. The gene expressions of TNF-α, IL6, and IL1-β were quantified. Bar graph represented means ± SE. The data were analyzed using one-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT. NT: nontreatment; PA: palmitic acid; PA + OA: palmitic acid with oleic acid; PA + MitoT: palmitic acid with MitoTEMPO.CC BY · PubMed Central
Figure 6 The effects of oleic acid and MitoTEMPO on morphological features of myotubes treated with PA. (a) Differentiated myotubes were cotreated with 0.3 mM palmitate and/or 0.5 mM oleate for 30 h. For some cells, 25 nM of MitoTEMPO was treated 1 h prior to palmitate treatment. Differentiated myotubes were stained with MF20 antibody and were visualized by florescence microscope (magnification = ×20). (b) Myotube width was quantified. (c) The expression of atrogenes was quantified. Bar graph represented means ± SE. Scale bar = 100 μm. The data were analyzed using one-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT, #p < 0.05 versus PA. NT: nontreatment; PA: palmitic acid; PA + OA: palmitic acid with oleic acid; PA + MitoT: palmitic acid with MitoTEMPO.
Figure 6 The effects of oleic acid and MitoTEMPO on morphological features of myotubes treated with PA. (a) Differentiated myotubes were cotreated with 0.3 mM palmitate and/or 0.5 mM oleate for 30 h. For some cells, 25 nM of MitoTEMPO was treated 1 h prior to palmitate treatment. Differentiated myotubes were stained with MF20 antibody and were visualized by florescence microscope (magnification = ×20). (b) Myotube width was quantified. (c) The expression of atrogenes was quantified. Bar graph represented means ± SE. Scale bar = 100 μm. The data were analyzed using one-way ANOVA followed by Tukey's post hoc test. ∗p < 0.05 versus NT, #p < 0.05 versus PA. NT: nontreatment; PA: palmitic acid; PA + OA: palmitic acid with oleic acid; PA + MitoT: palmitic acid with MitoTEMPO.CC BY · PubMed Central
Figure 7 A schematic diagram of the proposed mechanism of oleate-mediated prevention of atrophy in palmitate-rich environment.
Figure 7 A schematic diagram of the proposed mechanism of oleate-mediated prevention of atrophy in palmitate-rich environment.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 71 references

Research works printed but not linked: 1

  1. 10.1172/jci20174 · doi:10.1172/jci20174 · Paper page

Cited by

See all 48

Metadata

Authors
Lee, H., Lim, J.-Y., & Choi, S.-J.
Affiliations
  • Kyungsung University (KR)
  • Seoul National University (KR)
Corresponding author
Choi, Seung-Jun
Venue
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Published
2017-01
Volume
2017
Issue
1
Pages
2739721-2739721
ISSN
  • 1942-0994 (ISSN-L)
  • 1942-0900
OpenAlex
W2752624889
Cited by
43
References
71
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 8 · 2022: 2 · 2021: 11 · 2020: 10 · 2019: 4 · 2018: 2
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Research Foundation of Korea (NRF-2016R1C1B2015125)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
oleate, palmitate, skeletal muscle atrophy, mitochondrial superoxide, mitochondrial reactive oxygen species, skeletal muscle myotubes, lipotoxicity, saturated fatty acids, unsaturated fatty acids, MitoTEMPO, mitochondrial fission, Drp1, Fis1, myostatin, atrogin-1, TNF-α, interleukin-6, pro-inflammatory gene expression
MeSH terms
Atrophy, Humans, Mitochondria, Palmitates, Reactive Oxygen Species, Muscle, Skeletal, Muscle Fibers, Skeletal, Oleic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oleate prevents palmitate-induced atrophy via modulation of mitochondrial ROS production in skeletal myotubes. https://app.cochat.ai/papers/10.1155/2017/2739721
The paper
Lee, H., Lim, J.-Y., & Choi, S.-J. (2017). Oleate prevents palmitate-induced atrophy via modulation of mitochondrial ROS production in skeletal myotubes. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2017/2739721

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.